Prevalence of diabetic peripheral neuropathy among type II diabetic patients in King Fahd University Hospital, Khobar, Kingdom of Saudi Arabia

References

• Al-Geffari M. Comparison of different screening tests for diagnosis of diabetic peripheral neuropathy in primary health care setting. Int J Health Sci (Qassim). 2012;6(2):127–134.
   PubMedGoogle Scholar
• Juster-Switlyk K, Smith A. Updates in diabetic peripheral neuropathy. F1000Res. 2016;5:738.
   Google Scholar
• Tesfaye S, Wilhelm S, Lledo A, et al. Duloxetine and pregabalin: high-dose monotherapy or their combination? The “COMBO-DN study” – a multinational, randomized, double-blind, parallel-group study in patients with diabetic peripheral neuropathic pain. Pain. 2013;154(12):2616–2625.
   PubMed Web of Science ®Google Scholar
• Tesfaye S. Neuropathy in diabetes. Medicine (Baltimore). 2019;47(2):92–99.
   Google Scholar
• Boyle J, Eriksson MEV, Gribble L, et al. Randomized, placebo-controlled comparison of amitriptyline, duloxetine, and pregabalin in patients with chronic diabetic peripheral neuropathic pain: impact on pain, polysomnographic sleep, daytime functioning, and quality of life. Diabetes Care. 2012;35(12):2451–2458.
   PubMed Web of Science ®Google Scholar
• Battula P, Afreen S, Meena E, et al. Prevalence of sensory peripheral neuropathy in diabetic patients at diabetes care centre: a cross sectional study. Int J Res Med Sci. 2017;5(9):4066.
   Google Scholar
• Nisar M, Asad A, Waqas A, et al. Association of diabetic neuropathy with duration of type 2 diabetes and glycemic control. Cureus. 2015. DOI:10.7759/cureus.302.
   PubMed Web of Science ®Google Scholar
• Li L, Chen J, Wang J, et al. Prevalence and risk factors of diabetic peripheral neuropathy in type 2 diabetes mellitus patients with overweight/obese in Guangdong province, China. Prim Care Diabetes. 2015;9(3):191–195.
   PubMed Web of Science ®Google Scholar
• Khawaja N, Abu-Shennar J, Saleh M, et al. The prevalence and risk factors of peripheral neuropathy among patients with type 2 diabetes mellitus; the case of Jordan. Diabetol Metab Syndr. 2018;10(1).
   Google Scholar
• Mohamed H, Al Lenjawi B, Fahim Al Hamadani Z. et al. Prevalence and correlates of diabetic peripheral neuropathy in a newly developing country: a cross-sectional study. J Diabetic Foot Complications. 2016;8(2):31–37.
   Google Scholar
• Bouhassira D, Letanoux M, Hartemann A. Chronic pain with neuropathic characteristics in diabetic patients: a french cross-sectional study. PLoS ONE. 2013;8(9):e74195.
   PubMed Web of Science ®Google Scholar
• Garoushi S, Johnson MI, Tashani OA. A cross-sectional study to estimate the point prevalence of painful diabetic neuropathy in Eastern Libya. BMC Public Health. 2019;19(1). DOI:10.1186/s12889-018-6374-9
   PubMedGoogle Scholar
• Davies M, Brophy S, Williams R, et al. The prevalence, severity, and impact of painful diabetic peripheral neuropathy in type 2 diabetes. Diabetes Care. 2006;29(7):1518–1522.
   PubMed Web of Science ®Google Scholar
• Cortez J, Reis C, Cardoso Y, et al. Prevalence of neuropathic pain and associated factors in diabetes mellitus type 2 patients seen in outpatient setting. Revista Dor. 2014;15(4). DOI:10.5935/1806-0013.20140055.
   Google Scholar
• Chahbi Z, Lahmar B, El Hadri S, et al. The prevalence of painful diabetic neuropathy in 300 Moroccan diabetics. Pan Afr Med J. 2018;31. DOI:10.11604/pamj.2018.31.158.14687.
   PubMed Web of Science ®Google Scholar
• Jambart S, Ammache Z, Haddad F, et al. Prevalence of painful diabetic peripheral neuropathy among patients with diabetes mellitus in the Middle East Region. J Int Med Res. 2011;39(2):366–377.
   PubMed Web of Science ®Google Scholar
• Halawa M, Karawagh A, Zeidan A, et al. Prevalence of painful diabetic peripheral neuropathy among patients suffering from diabetes mellitus in Saudi Arabia. Curr Med Res Opin. 2009;26(2):337–343.
   Web of Science ®Google Scholar
• Wang DD, Bakhotmah BA, Hu FB, et al. Prevalence and correlates of diabetic peripheral neuropathy in a saudi arabic population: a cross-sectional study. PLoS ONE. 2014;9(9):e106935.
   PubMed Web of Science ®Google Scholar
• Abraham M, Tyng T, Rekha K, et al. Comparison of four screening methods for diabetic peripheral neuropathy in type 2 diabetes mellitus patients: a cross sectional study. Res J Pharm Technol. 2018;11(12):5551.
   Google Scholar
• Moghtaderi A, Bakhshipour A, Rashidi H. Validation of Michigan neuropathy screening instrument for diabetic peripheral neuropathy. Clin Neurol Neurosurg. 2006;108(5):477–481.
   PubMed Web of Science ®Google Scholar
• Almohisen A, Almuhaysen L, Alhatlany K, et al. Prevalence and risk factors of diabetic neuropathy in Qassim, Saudi Arabia. 8(2):2020;23-25.
   Google Scholar
• Algeffari MA. Painful diabetic peripheral neuropathy among Saudi diabetic patients is common but under-recognized: multicenter cross-sectional study at primary health care setting. J Family Community Med. 2018;25(1):43–47.
   PubMed Web of Science ®Google Scholar
• Sendi R, Mahrus A, Saeed R, et al. Diabetic peripheral neuropathy among Saudi diabetic patients: a multicenter cross-sectional study at primary health care setting. J Family Med Prim Care. 2020;9(1):197–201.
   PubMedGoogle Scholar
• Ponirakis G, Elhadd T, Chinnaiyan S, et al. Prevalence and risk factors for painful diabetic neuropathy in secondary healthcare in Qatar. J Diabetes Investig. 2019;10(6):1558–1564.
   PubMed Web of Science ®Google Scholar
• Hicks CW, Selvin E. Epidemiology of peripheral neuropathy and lower extremity disease in diabetes. Curr Diab Rep. 2019;19:10.
   PubMed Web of Science ®Google Scholar
• Elbarsha A, Hamedh M, Elsaeiti M. Prevalence and risk factors of diabetic peripheral neuropathy in patients with Type 2 diabetes mellitus. Ibnosina J of Med Biomed Sci. 2019;11(1):25–28.
   Google Scholar
• Amour A, Chamba N, Kayandabila J, et al. (2019) Prevalence, patterns, and factors associated with peripheral neuropathies among diabetic patients at tertiary hospital in the Kilimanjaro Region: descriptive cross-sectional study.
   Google Scholar
• Shibabaw W, Akalu Y, Work Y, et al. Prevalence of diabetic peripheral neuropathy in Africa: a systematic review and meta-analysis. BMC Endocr Disord. 2020;20:49.
   PubMed Web of Science ®Google Scholar
• Meena S, RC M. Prevalence of peripheral neuropathy and peripheral artery disease in diabetic patients attending a tertiary care hospital. Int J Adv Med. 2019;6(5):1493.
   Google Scholar
• Darivemula S, Nagoor K, Patan SK, et al. Prevalence and its associated determinants of diabetic peripheral neuropathy (DPN) in individuals having type-2 diabetes mellitus in Rural South India. Indian J Community Med. 2019;44(2):88–91.
   PubMed Web of Science ®Google Scholar
• Javed A, Furqan A, Zaheer M, et al. Gender based differences in diabetic peripheral neuropathy. Pak J Neurol Sci. 2014;9(4):20-23
   Google Scholar
• Baderca F, Timar B, Popescu S, et al. Age as an independent factor for the development of neuropathy in diabetic patients. Clin Interv Aging. 2016:313. DOI:10.2147/CIA.S97295.
   PubMed Web of Science ®Google Scholar
• Callaghan BC, Gao L, Li Y, et al. Diabetes and obesity are the main metabolic drivers of peripheral neuropathy. Ann Clin Transl Neurol. 2018 Feb 14;5(4):397–405.
   PubMed Web of Science ®Google Scholar
• Llewelyn J. the diabetic neuropathies: types, diagnosis and management. J Neurol Neurosurg. 2003;74(90002):15–19.
   Google Scholar
• Rawat D. Retinopathy and its associated factors in type 2 diabetes mellitus in rural population of central India. J Med Sci Clin Res. 2019;7(6). DOI: 10.18535/jmscr/v7i6.17.
   Google Scholar
• Diabetes and Foot Care. Diabetes.co.uk. [Internet]. 2019. Available from: https://www.diabetes.co.uk/diabetes-footcare.html
   Google Scholar